This inventor holds 3 USPTO granted patents. Top assignee: Schering Corporation. Active years: 1992-2011.
Location History:
- Plainsboro, NJ (US) (1992 - 1995)
- Princeton, NJ (US) (2011)
Company Filing History:
Years Active: 1992-2011
Title: The Innovative Contributions of Elizabeth B. Smith
Introduction
Elizabeth B. Smith is a notable inventor based in Plainsboro, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting orphan G protein-coupled receptors. With a total of 3 patents to her name, her work has the potential to impact various medical conditions.
Latest Patents
One of her latest patents focuses on "Modulators of the orphan G protein-coupled receptors GPR78 and GPR26." This invention relates to the use of the interaction between the GPR78 polypeptide or the GPR26 polypeptide and their identified ligands and antagonists. It serves as the basis for screening methods aimed at identifying agents that modulate the activity of these receptors for diagnostic and therapeutic purposes. The agents identified through these methods have applications in treating GPR78- and/or GPR26-mediated disorders, including neurological disorders such as anxiety, metabolic disorders, cardiovascular disorders, hormone-related disorders, vascular disorders, and hyperproliferative disorders like cancer.
Another significant patent involves "Actinomadura brunnea var. antibiotica strains." This patent discloses the use of 7-Chloro-8-methoxytetracycline, isolated from antibiotic ES-119 and antibiotic Tet. 7, produced by fermentation of mutants of Actinomadura brunnea. The antibiotic is effective against both gram-positive and gram-negative organisms.
Career Highlights
Elizabeth B. Smith is currently associated with Schering Corporation, where she continues to innovate and contribute to the field of pharmaceuticals. Her work has been instrumental in advancing therapeutic options for various diseases.
Collaborations
Throughout her career, Elizabeth has collaborated with notable colleagues, including Michael J. Ryan and Suke Wang. These partnerships have further enhanced her research and development efforts.
Conclusion
Elizabeth B. Smith's innovative work in biotechnology and her contributions to the development of therapeutic agents highlight her importance in the field. Her patents reflect a commitment to addressing significant medical challenges, making her a valuable inventor in the industry.